new article

from

http://www.treatmentactiongroup.org/uploadedFiles/About/Publications/TAG_Publications/2009/2009%20Pipeline%20web.pdf

Mentions how Apricitabine is the most promising NRTI in development and also this quote:

"Bevirimat, ibalizumab, and apricitabine are virtually the only hope for people who
desperately need at least two new drugs from new classes to overcome HIV with
resistance to every other available drug"

Whilst this stock has been ignored in recent times the drug is too good to be ignored, in my opinion. Eventually there will be a deal.